|
|
Enter your search term above and find:
· CAS Numbers
· Molecular Formulas
· Synonyms
· Sites/Web Search
· Suppliers
· Resources
|
|
|
|
|
|
|
|
|
|
|
Synonyms:
[fewer]
14462_FLUKA, 19003_FLUKA, 21090-60-8, 23089-26-1, 25428-43-7, 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (alphaR,1R)-rel-, 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, (R*,R*)-, 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (R*,R*)-, 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (R*,R*)- (9CI), 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [R-(R*,R*)]-, 3-Cyclohexene-1-methanol, .alpha.,4-dimethyl-.alpha.-(4-methyl-3-pentenyl)-, [S-(R*,R*)]-, 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (S-(theta,theta))-, 3-Cyclohexene-1-methanol, alpha,4-dimethyl-alpha-(4-methyl-3-pentenyl)-, (theta,theta)-(+/-)-, 515-69-5, 5-HEPTEN-2-OL, 6-METHYL-2-(4-METHYL-3-CYCLOHEXEN-1-YL)-, 63601-23-0, 67375-41-1, 6-epi-.alpha.-Bisabolol, (-)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, 6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, 6-methyl-2-(4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol, 7-epi-.alpha.-Bisabolol, (−)-6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, (−)-alpha-Bisabolol, alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)-3-cyclohexene-1-methanol, alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)-3-cyclohexene-1-meth- anol, .alpha.-Bisabolol, (-)-.alpha.-Bisabolol, (+)-.alpha.-Bisabolol, alpha-Bisabolol, alpha-Bisabolol (-)-form, alpha-Bisabolol, L-, Bisabolol, Bisbalol, C15H26O, EINECS 208-205-9, EINECS 245-423-3, EINECS 246-973-7, epi-.alpha.-Bisabolol, LEVOMENOL, Levomenol [INN], Levomenolum [INN-Latin], LS-74679, NSC606842, (R*,R*)-(1)-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol, (R*,R*)-alpha,4-Dimethyl-alpha-(4-methyl-3-pentenyl)cyclohex-3-ene-1-methanol, ST5320075
|
|
|
|
|
|
|
|
|
|
|
|
|
|
